Boston Scientific Corporation (LON:0HOY)
98.35
-0.56 (-0.57%)
At close: Nov 4, 2025
Boston Scientific Market Cap
Boston Scientific has a market cap or net worth of 112.31 billion as of November 5, 2025. Its market cap has increased by 12.94% in one year.
Market Cap
112.31B
Enterprise Value
120.75B
Revenue
14.39B
Ranking
n/a
PE Ratio
54.09
Stock Price
98.35
Market Cap Chart
Since May 19, 1992, Boston Scientific's market cap has increased from 876.49M to 112.31B, an increase of 12,713.97%. That is a compound annual growth rate of 15.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2025 | 112.31B | 6.81% |
| Dec 31, 2024 | 105.15B | 58.15% |
| Dec 29, 2023 | 66.49B | 20.88% |
| Dec 30, 2022 | 55.00B | 23.04% |
| Dec 31, 2021 | 44.71B | 18.57% |
| Dec 31, 2020 | 37.70B | -20.77% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 194.27B |
| GSK plc | 71.94B |
| Haleon | 31.88B |
| Smith & Nephew | 12.02B |
| ConvaTec Group | 4.86B |
| Hikma Pharmaceuticals | 3.90B |
| HUTCHMED (China) | 2.01B |
| Genus | 1.65B |